Please select the option that best describes you:

Would you provide TDM1 or capecitabine for residual disease in HR negative patients with HER2 positivity based on copy number alone?  

For patients with hormone negative breast cancer and HER2 positive only by copy number, do you give TDM1 for residual disease or capecitabine?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at R and B Lewis Cancer Care Center
How do you manage triple positive metastatic breas...
Sign in or Register to read more